作者: Nikhila Vengala
DOI:
关键词:
摘要: Diabetic nephropathy remains the foremost common cause of end-stage nephritic disease worldwide. The present standard medical care for diabetic kidney involves rigorous vital sign management via blockade renin–angiotensin system and control hyperglycemia. Despite these methods, continues to be seen progress unrelentingly. A pressing would like novel therapeutic agents have burning endless basic science research outcomes clinical trials within look an additional specific care. Throughout method, solely a couple accessory shown experimental promise even fewer incontestable effect in trials. Treatment include glycemic management, treatment hypertension, lipidemia, cease smoking, protein restriction renal replacement therapy. Complex approach includes combined targeting hyperglycemia, high blood pressure, microalbuminuria, dyslipidemia.